Low Alzheimer's disease prevalence in rheumatoid arthritis patients is unrelated to ApoE genotype

Small, 1997, Diagnosis and treatment of Alzheimer disease and related disorders, JAMA, 278, 1363, 10.1001/jama.1997.03550160083043 McGeer, 1994, Neuroimmune mechanisms in Alzheimer disease pathogenesis, Alzheimer Dis. Assoc. Disord., 8, 149, 10.1097/00002093-199408030-00001 Strittmatter, 1993, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 90, 1977, 10.1073/pnas.90.5.1977 Saunders, 1993, Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease, Neurology, 43, 1467, 10.1212/WNL.43.8.1467 Chartier-Harlin, 1994, Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease, Hum. Mol. Genet., 3, 569, 10.1093/hmg/3.4.569 Farrer, 1997, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis, JAMA, 278, 1349, 10.1001/jama.1997.03550160069041 Corder, 1994, Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease, Nat. Genet., 7, 180, 10.1038/ng0694-180 Roses, 1996, Apolipoprotein E alleles as risk factors in Alzheimer disease, Annu. Rev. Med., 47, 387, 10.1146/annurev.med.47.1.387 McGeer, 1990, Anti-inflammatory drugs and Alzheimer disease, Lancet, 335, 1037, 10.1016/0140-6736(90)91101-F Myllykangas-Luosujarvi, 1994, Alzheimer's disease and rheumatoid arthritis, Br. J. Rheumatol., 33, 501, 10.1093/rheumatology/33.5.501 McGeer, 1996, Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies, Neurology, 47, 425, 10.1212/WNL.47.2.425 McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 Arnett, 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum., 31, 315, 10.1002/art.1780310302 Miller, 1988, A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res., 16, 1215, 10.1093/nar/16.3.1215 Hixson, 1990, Restriction isotyping of human apolipoprotein E by gene amplification and cleavage HhaI, J. Lipid Res., 31, 545, 10.1016/S0022-2275(20)43176-1 Mahley, 1988, Apolipoprotein E: cholesterol transport protein with expanding role in cell biology, Science, 240, 622, 10.1126/science.3283935 Strittmatter, 1994, Isoform-specific interactions of apolipoprotein E with microtubule associated protein tau: implications for Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A., 91, 1183, 10.1073/pnas.91.23.11183 Breitner, 1996, Inflammatory processes and anti-inflammatory drugs in Alzheimer's disease: a current apraisal, Neurobiol. Aging, 17, 789, 10.1016/0197-4580(96)00109-1 MacKenzie, 1998, Non-steroidal anti-inflammatory drug use and Alzheimer-type pathology in aging, Neurology, 50, 986, 10.1212/WNL.50.4.986 Hasegawa, 1996, High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosis, Arthritis Rheum., 39, 1728, 10.1002/art.1780391016 Slooter, 1997, Genetic epidemiology of Alzheimer disease, Epidemiol. Rev., 19, 107, 10.1093/oxfordjournals.epirev.a017933 Curran, 1997, HLA-DR antigens associated with major risk for late-onset Alzheimer's disease, NeuroReport, 8, 1467, 10.1097/00001756-199704140-00028 Gao, 1990, HLA-DR alleles with naturally occurring amino acid substitutions and risk for development of rheumatoid arthritis, Arthritis Rheum., 33, 939, 10.1002/art.1780330704